207 Safety of Rifaximin in Patients With Hepatic Encephalopathy: Results of a Randomized, Phase 3, Placebo-controlled Clinical Trial
Year: 2009
Type: article
Source: Journal of Hepatology
Authors: K. Mullen, S. Sigal, M. Sheikh, N. Bass, F. Poordad, K. Merchant, S. Huang, A. Shaw, E. Bortey, W. Forbes
Institutions: University of Copenhagen, The Royal Free Hospital, Hvidovre Hospital, University College London, Case Western Reserve University, Cornell University, Rigshospitalet, University of Surrey, Weill Cornell Medicine, University of California, San Francisco, Cedars-Sinai Medical Center, Salix Pharmaceuticals (United States)
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2029282156